LISINOPRIL-GA lisinopril 2.5mg (as dihydrate) tablet blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

lisinopril dihydrate (Equivalent: lisinopril, Qty 2.5 mg)

Disponible desde:

Medis Pharma Pty Ltd

Designación común internacional (DCI):

Lisinopril dihydrate

formulario farmacéutico:

Tablet, uncoated

Composición:

Excipient Ingredients: mannitol; calcium hydrogen phosphate dihydrate; maize starch; magnesium stearate

Vía de administración:

Oral

Unidades en paquete:

100, 28 tablets, 14, 30 tablets, 56 tablets, 10, 84 tablets, 50

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Hypertension: For treatment of hypertension, lisinopril may be used alone or concomitantly with other classes of antihypertensive agents. Sufficient data have not been provided to support the use of lisinopril in severe hypertension or renovascular hypertension. Congestive heart failure: For treatment of heart failure, it is recommended that lisinopril be administered with a diuretic. Acute myocardial infarction: For treatment of acute myocardial infarction in haemodynamically stable patients, defined as patients who are not in cardiogenic shock and who have a systolic blood pressure greater than 100 mmHg, lisinopril may be initiated within 24 hours of an acute myocardial infarction.

Resumen del producto:

Visual Identification: White to almost white, circular, biconvex, uncoated tablets with '2.5' embossing on one side and 'BL' embossing on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Estado de Autorización:

Registered

Fecha de autorización:

2006-07-27